Literature DB >> 19696265

Mucinous adenocarcinoma of the prostate: MRI and MR spectroscopy features.

Antonio C Westphalen1, Fergus V Coakley, John Kurhanewicz, Galen Reed, Zhen J Wang, Jeffry P Simko.   

Abstract

OBJECTIVE: The purpose of this study was to investigate the MRI and MR spectroscopy features of mucinous adenocarcinoma of the prostate.
CONCLUSION: MRI and MR spectroscopy do not appear to provide the ability to reliably detect the lakes of extracellular mucin seen in mucinous adenocarcinoma of the prostate.

Entities:  

Mesh:

Year:  2009        PMID: 19696265      PMCID: PMC2801739          DOI: 10.2214/AJR.08.1495

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  14 in total

1.  Clinical application of BASING and spectral/spatial water and lipid suppression pulses for prostate cancer staging and localization by in vivo 3D 1H magnetic resonance spectroscopic imaging.

Authors:  R G Males; D B Vigneron; J Star-Lack; S C Falbo; S J Nelson; H Hricak; J Kurhanewicz
Journal:  Magn Reson Med       Date:  2000-01       Impact factor: 4.668

2.  Dualband spectral-spatial RF pulses for prostate MR spectroscopic imaging.

Authors:  A A Schricker; J M Pauly; J Kurhanewicz; M G Swanson; D B Vigneron
Journal:  Magn Reson Med       Date:  2001-12       Impact factor: 4.668

Review 3.  The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma.

Authors:  Jonathan I Epstein; William C Allsbrook; Mahul B Amin; Lars L Egevad
Journal:  Am J Surg Pathol       Date:  2005-09       Impact factor: 6.394

Review 4.  Role of magnetic resonance imaging and magnetic resonance spectroscopic imaging before and after radiotherapy for prostate cancer.

Authors:  Antonio C Westphalen; David A McKenna; John Kurhanewicz; Fergus V Coakley
Journal:  J Endourol       Date:  2008-04       Impact factor: 2.942

5.  MR imaging features of pelvic mucinous carcinomas.

Authors:  S M Hussain; E K Outwater; E S Siegelman
Journal:  Eur Radiol       Date:  2000       Impact factor: 5.315

6.  Mucinous adenocarcinoma of the prostate gland.

Authors:  J I Epstein; P H Lieberman
Journal:  Am J Surg Pathol       Date:  1985-04       Impact factor: 6.394

7.  Mucinous adenocarcinoma of the prostate does not confer poor prognosis.

Authors:  Brian R Lane; Cristina Magi-Galluzzi; Alwyn M Reuther; Howard S Levin; Ming Zhou; Eric A Klein
Journal:  Urology       Date:  2006-10       Impact factor: 2.649

8.  Mucinous appendiceal neoplasms: preoperative MR staging and classification compared with surgical and histopathologic findings.

Authors:  Russell N Low; Robert M Barone; Jonathan M Gurney; Wayne D Muller
Journal:  AJR Am J Roentgenol       Date:  2008-03       Impact factor: 3.959

9.  Mucinous carcinomas involving the prostate: atypical findings at MR imaging.

Authors:  E Outwater; M L Schiebler; J E Tomaszewski; M D Schnall; H Y Kressel
Journal:  J Magn Reson Imaging       Date:  1992 Sep-Oct       Impact factor: 4.813

Review 10.  Magnetic resonance imaging and spectroscopic imaging of prostate cancer.

Authors:  Fergus V Coakley; Aliya Qayyum; John Kurhanewicz
Journal:  J Urol       Date:  2003-12       Impact factor: 7.450

View more
  8 in total

Review 1.  Prostate MRI and 3D MR spectroscopy: how we do it.

Authors:  Sadhna Verma; Arumugam Rajesh; Jurgen J Fütterer; Baris Turkbey; Tom W J Scheenen; Yuxi Pang; Peter L Choyke; John Kurhanewicz
Journal:  AJR Am J Roentgenol       Date:  2010-06       Impact factor: 3.959

Review 2.  Advancements in MR imaging of the prostate: from diagnosis to interventions.

Authors:  David Bonekamp; Michael A Jacobs; Riham El-Khouli; Dan Stoianovici; Katarzyna J Macura
Journal:  Radiographics       Date:  2011 May-Jun       Impact factor: 5.333

3.  What kind of prostate cancers do we miss on multiparametric magnetic resonance imaging?

Authors:  Pieter Julien Luc De Visschere; Leslie Naesens; Louis Libbrecht; Charles Van Praet; Nicolaas Lumen; Valérie Fonteyne; Eva Pattyn; Geert Villeirs
Journal:  Eur Radiol       Date:  2015-07-03       Impact factor: 5.315

Review 4.  The role of MRI in prostate cancer active surveillance.

Authors:  Linda M Johnson; Peter L Choyke; William D Figg; Baris Turkbey
Journal:  Biomed Res Int       Date:  2014-11-30       Impact factor: 3.411

5.  Targeted Prostate Biopsy Using 68Gallium PSMA-PET/CT for Image Guidance.

Authors:  Demetrios N Simopoulos; Shyam Natarajan; Tonye A Jones; Wolfgang P Fendler; Anthony E Sisk; Leonard S Marks
Journal:  Urol Case Rep       Date:  2017-06-03

6.  Rhabdomyosarcoma of the prostate with bladder and urethral infiltration: A case report.

Authors:  Sahat Matondang; Benedicta M Suwita; Taufik Budianto; Yayi Dwina
Journal:  Urol Case Rep       Date:  2020-04-10

7.  Case Report: Prostate Adenocarcinoma With Mucinous Features of Normal-Level Serum PSA, Atypical Imaging, Biopsy-Negative, and Peculiar Urethrocystoscopic Manifestation.

Authors:  Yao Zhang; Hua Shen; Kai Liao; Weili Wu; Jiuming Li; Hongbo Yu; Hongfei Wu; Zengjun Wang
Journal:  Front Oncol       Date:  2020-12-23       Impact factor: 6.244

Review 8.  MRI in prostate cancer.

Authors:  Mahyar Ghafoori; Manijeh Alavi; Mounes Aliyari Ghasabeh
Journal:  Iran Red Crescent Med J       Date:  2013-12-05       Impact factor: 0.611

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.